Heron Therapeutics Inc.

15/07/2024 | Press release | Distributed by Public on 15/07/2024 12:03

Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.